Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Lehman

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
The Journal of Rheumatology|September 12, 2008
Abatacept for refractory juvenile idiopathic arthritis-associated uveitis- a case reportSheila Angeles-Han, Thomas Flynn, Thomas Lehman
Preventing Chronic Disease|December 8, 2017
Overweight and Obesity in Local Media: An Analysis of Media Coverage in CDC-Funded CommunitiesChristopher N Thomas, Derek Inokuchi, Thomas Lehman, et al.
Preventing Chronic Disease|July 26, 2019
Use of Mass Communication by Public Health Programs in Nonmetropolitan RegionsJennifer M Kreslake, Allison Elkins, Christopher N Thomas, et al.
European Journal of Anaesthesiology|January 2, 2025
Chronic postsurgical pain ICD11 definition is important but not always usableValeria Martinez, Thomas Lehman, Esther M Pogatzki Zahn, et al.
Hand (New York, N.Y.)|June 13, 2019
Carpometacarpal Fracture-Dislocations: A Retrospective Review of Injury Characteristics and Radiographic OutcomesGarrett Steinmetz, Evan Corning, Trent Hulse, et al.
Plos Currents|September 22, 2016
Qualitative Analysis of Surveyed Emergency Responders and the Identified Factors That Affect First Stage of Primary Triage Decision-Making of Mass Casualty IncidentsKelly R Klein, Frederick M Burkle, Raymond Swienton, et al.
Arthritis Research & Therapy|December 8, 2018
Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trialVibeke Strand, Evo Alemao, Thomas Lehman, et al.
Frontiers in Public Health|September 5, 2017
Readiness for Radiological and Nuclear Events among Emergency Medical PersonnelCham E Dallas, Kelly R Klein, Thomas Lehman, et al.
ACR Open Rheumatology|June 23, 2025
Impact of Delay of Treatment With Disease-Modifying Antirheumatic Drugs in Psoriatic Arthritis: The CorEvitas Psoriatic Arthritis/Spondyloarthritis RegistryPhilip J Mease, Miroslawa Nowak, Jiyoon Choi, et al.
Rheumatology (Oxford, England)|October 18, 2024
Deucravacitinib, a selective, TYK2 inhibitor, in psoriatic arthritis: achievement of minimal disease activity components in a phase 2 trialArthur Kavanaugh, Laura C Coates, Philip J Mease, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
The Journal of Rheumatology|September 12, 2008
Abatacept for refractory juvenile idiopathic arthritis-associated uveitis- a case reportSheila Angeles-Han, Thomas Flynn, Thomas Lehman
Preventing Chronic Disease|December 8, 2017
Overweight and Obesity in Local Media: An Analysis of Media Coverage in CDC-Funded CommunitiesChristopher N Thomas, Derek Inokuchi, Thomas Lehman, et al.
Preventing Chronic Disease|July 26, 2019
Use of Mass Communication by Public Health Programs in Nonmetropolitan RegionsJennifer M Kreslake, Allison Elkins, Christopher N Thomas, et al.
European Journal of Anaesthesiology|January 2, 2025
Chronic postsurgical pain ICD11 definition is important but not always usableValeria Martinez, Thomas Lehman, Esther M Pogatzki Zahn, et al.
Hand (New York, N.Y.)|June 13, 2019
Carpometacarpal Fracture-Dislocations: A Retrospective Review of Injury Characteristics and Radiographic OutcomesGarrett Steinmetz, Evan Corning, Trent Hulse, et al.
Plos Currents|September 22, 2016
Qualitative Analysis of Surveyed Emergency Responders and the Identified Factors That Affect First Stage of Primary Triage Decision-Making of Mass Casualty IncidentsKelly R Klein, Frederick M Burkle, Raymond Swienton, et al.
Arthritis Research & Therapy|December 8, 2018
Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trialVibeke Strand, Evo Alemao, Thomas Lehman, et al.
Frontiers in Public Health|September 5, 2017
Readiness for Radiological and Nuclear Events among Emergency Medical PersonnelCham E Dallas, Kelly R Klein, Thomas Lehman, et al.
ACR Open Rheumatology|June 23, 2025
Impact of Delay of Treatment With Disease-Modifying Antirheumatic Drugs in Psoriatic Arthritis: The CorEvitas Psoriatic Arthritis/Spondyloarthritis RegistryPhilip J Mease, Miroslawa Nowak, Jiyoon Choi, et al.
Rheumatology (Oxford, England)|October 18, 2024
Deucravacitinib, a selective, TYK2 inhibitor, in psoriatic arthritis: achievement of minimal disease activity components in a phase 2 trialArthur Kavanaugh, Laura C Coates, Philip J Mease, et al.
Pageof 3